Peptoids are a novel class of biomimetic, non-natural, sequence-specific heteropolymers that resist proteolysis, exhibit potent biological activity, and fold into higher order nanostructures. Structurally similar to peptides, peptoids are poly N-substituted glycines, where the side chains are attached to the nitrogen rather than the alpha-carbon. Their ease of synthesis and structural diversity allows testing of basic design principles to drive de novo design and engineering of new biologically-active and nanostructured materials.
2. Add 100 mg (0.06 mmol) of Rink amide resin to a fritted reaction vessel. Swell the resin by adding 2 mL of dimethylformamide (DMF). Agitate by shaking or bubbling for 10 minutes. Drain the solution by vacuum to isolate the swelled resin. 3. Add 1 mL of 20% 4-methylpiperidine in DMF (v/v) to deprotect the Fmoc group. Agitate for 2 minutes and drain. Repeat with a 12 minute incubation. 4. Rinse the resin by adding 2 mL of DMF, agitating for 15 seconds, and draining. Repeat 3x. 5. Bromoacetylation: Add 1 mL of 0.6 M bromoacetic acid (0.6 mmol) in DMF and 86 μL of N,N'-diisopropylcarbodiimide (0.93 equivalent, 0.56 mmol). Incubate with gentle bubbling for 30 minutes, then drain and rinse with 2 mL of DMF (repeat 4x). 6. Displacement: Add 1 mL of 1-2 M amine in N-methylpyrrolidinone. Incubate with bubbling for 30-120 minutes, then drain and rinse with DMF (4x 2 mL). 7. Continue to grow the peptoid chain by repeating the submonomer cycle, steps 1.5 (bromoacetylation) and 1.6 (displacement).
8. After the final displacement is done, rinse with 2 mL of DMF (repeat 4x), then 2 mL of dichloromethane (repeat 3x). Cap and store the reaction vessel until cleavage. 9. Pause in synthesis (optional): To pause during a peptoid synthesis, finish the displacement reaction and continue to step 1.8. To continue growing the peptoid chain, restart the synthesis by re-swelling the dried resin (step 1.2) and repeating the submonomer cycle (step 1.5 and 1.6). The resin can be dried and stored after any displacement except the 2nd displacement because the resin-peptoid conjugate may form a cyclic diketopiperazine side product. 10. For multiple simultaneous syntheses, a solid-phase extraction vacuum manifold is recommended to maximize efficiency. Peptoid synthesis can also be automated by properly programming methods in commercially available peptide synthesizers, such as the Aapptec Apex 396, CEM Liberty microwave synthesizer and Protein Technologies Inc. Prelude synthesizer.
Peptoid Nanosheet Formation
This section describes the protocol to form sheets from a single-chain, sequence specific, amphiphilic 36-mer peptoid (Fig. 1) . After the peptoid strand is synthesized, purified, and lyophilized as described above, the resulting white powder is dissolved in DMSO to make a 2 mM stock solution.
1. Prepare 500 μL of 20 μM peptoid solution in sheet formation buffer (10 mM Tris-HCl, 100 mM NaCl, pH 8.0 in water) in a 1 dram glass vial. First, add 445 μL of Milli-Q water, 50 μL of 10x sheet formation buffer, and vortex to mix. Then, add 5 μL of 2 mM peptoid stock solution and gently swirl solution. Cap the glass vial. 2. Sheets are formed by the gentle agitation of the dilute aqueous peptoid solution. Slowly tilting the glass vial from the horizontal position to the upright position results in sheets. Gentle shaking also yields sheets; however, the sheets tend to be smaller and with fewer straight edges. A more thorough analysis of the sheet formation mechanism is reported separately. 3. For many high-quality sheets, rotate the glass vials about the horizontal axis slowly (<1 RPM) for one to three days. An Appropriate Technical Resources RKVSD Rotamix tube rotator or a customized rocker can perform this continuously. 4. Dialysis of Nanosheets (optional): In certain applications, it may be necessary to remove any free peptoid chains or buffers/salts. Soak a Float-a-Lyzer 100 kD membrane in the desired buffer for 15 minutes. Load 500 μL peptoid sheet solution into the sample chamber. Soak in 500 mL of desired buffer, stirring with a magnetic stir bar at 60 rpm. Allow dialysis of sheets to proceed for 4 hours. Every hour, exchange with a fresh stock of buffer solution.
Fluorescence Microscopy of Nanosheets
1. Fluorescence images of the nanosheets were imaged with Nile Red, an environmentally sensitive dye whose fluorescence intensity increases when it is localized in hydrophobic environments (Fig. 2 ). 2. Add 1 μL of 100 μM Nile Red to 100 μL of the nanosheet solution to obtain a final concentration of 1 μM of Nile Red. 3. Make a 1% agarose solution in hot water and pour into a plastic Petri dish. Ensure the agarose solution is approximately 1/8 inch thick and allow the solution to cool undisturbed on a flat surface. After the agarose sets, use a spatula to cut and transfer 1 cm x 1 cm squares to a glass slide. 4. To collect the sheets in the same plane, spot 1 μL of sheet solution on the piece of agarose. Allow the agarose to absorb the buffer for 2 minutes, leaving the sheets at the surface. Image within 15 minutes, otherwise the agarose will begin to deform due to dehydration. 5. To image sheets in solution, load 15 μL inside a 20 mm diameter 0.12 mm gasket on a glass slide. Cover with a coverslip. If the sheets are simply sandwiched between a glass slide and coverslip without a gasket, many sheets will shear and the seemingly minor evaporation will cause the sheets to constantly move. 6. Image sheets under epifluorescence illumination (e.g. an Olympus IX81 inverted microscope fitted with an Andor iXonEM+ EMCCD spectra with a Texas red filter). (Fig. 3 ).
Scanning Electron Microscopy (SEM) of Nanosheets

Safety Notes:
1. Dimethylformamide and Dichloromethane are reasonably suspected carcinogens. 2. N,N'-Diisopropylcarbodiimide, 4-methylpiperdine and bromoacetic acid are hazardous to the skin, eyes, and respiratory tract. They should be used in the hood with care. It may be toxic if inhaled or absorbed through the skin, and exposure may result in sensitization. Empty containers retain product residue (liquid/vapor) and should be thoroughly rinsed before removing them from the hood. 3. TFA is a strong acid, and is extremely destructive to the upper respiratory tract, eyes, and skin. TFA is also volatile-keep concentrated solutions of TFA in the hood at all times to avoid respiratory damage. Use proper PPE, and caution when handling solutions of TFA. Change gloves promptly if they come in contact with TFA, and immediately clean up any spills.
Representative Results:
This section describes the synthesis, characterization, and purification of a sequence-specific 36-mer peptoid chain that folds into a highly ordered nanosheet 3 ( Fig. 1) .
The block-charge peptoid H-[Nae-Npe] 9 -[Nce-Npe] 9 -NH 2 was synthesized on 100 mg of Rink amide resin. A 2 M amine solution was used for all displacement reactions, which were carried out for 60 minutes for residue 1-18 and 120 minutes for residue 19-36. t-Butyl beta-alanine HCl was converted to the free base (see discussion) whereas phenethylamine and boc-ethylenediamine were both used directly. The resin was cleaved with 95% TFA, 2.5% triispropylsilane, 2.5% water for 2 hours. TFA was evaporated and the resulting viscous oil (~180 mg) was re-dissolved in 6 mL acetonitrile:water 1:1 (v/v). Product purity (Fig. 4) and presence of the product mass was confirmed by from analytical RP-HPLC (30-80% acetonitrile in water gradient, both containing 0.1% (v/v) TFA, at 1 mL/min over 30 minutes at 60 °C with a C18, 5 μm, 50 X 2 mm column) and MALDI (Fig. 5) .
Purification with reverse phase HPLC on a Vydac C18 column (10 μm, 22 mm x 250 mm) proceeded, using a gradient of 30-60% acetonitrile in water with 0.1% TFA over 60 minutes at 10 mL/min. The column was loaded with 60 mg of crude product for each chromatographic run. The purified fractions were combined based on purity from analytical RP-HPLC (Fig. 4) and lyophilized to yield ˜8 0 mg of a fluffy white powder.
Purified block-charge peptoid molecular weight was confirmed by MALDI. 1 μL of 100 μM purified peptoid in acetonitrile:water 1:1 (v/v) was mixed with 1 μL of matrix (5 mg/mL α-cyano-4-hydroxycinnamic acid in acetonitrile:water 1:1 v/v and 0.1% TFA) and 1 μL was spotted on the MALDI plate. After the sample air-dried, it was placed in the Applied Biosystem/MDS SCIEX 4800 MALDI TOF/TOF Analyzer. The acquisition and processing modes were linear low mass. The calculated weight was entered in the targeted mass to automatically adjust for the delay time.
The laser intensity was set to 3400. The observed mass, 4981.2, matches closely to the calculated mass of 4981.74.
The lyophilized purified powder was dissolved in DMSO to make a 2 mM stock solution, which can be stored at 4 °C. Sheets were prepared by aforementioned protocol and imaged with fluorescence optical microscopy and SEM ( Fig. 2 and 3) . A variety of shapes with feature sizes ranging up to 300 μm are observed, and notably, straight edges are prominent. 
Discussion
Applications and Significance
This protocol describes a simple and efficient method of peptoid synthesis and the aqueous self-assembly of the peptoids into nanosheets. Most laboratories are easily capable of synthesizing peptoids because inexpensive materials, basic expertise and straightforward techniques are utilized 4 . Likewise, the self-assembly of ultra-thin, highly-ordered nanosheets merely requires repeated tilting a vial of a dilute aqueous peptoid solution 2 . Peptoids are promising materials for biomedical and nanoscience research because they are robust and synthetically flexible yet sequence-specific and highly tunable 5 . Peptoids have demonstrated biological activity (therapeutics 6, 7 , diagnostics 8 , intracellular delivery [9] [10] ) and folding into hierarchical nanostructures 3, [11] [12] [13] [14] 
